Prognostic Analysis of Completely Resected Lung Adenocarcinoma with Uncommon EGFR Mutations: CReGYT-01 EGFR Study

被引：0

作者：

Hayasaka, K. ^{[1
,2
]}

Haratake, N. ^{[3
]}

Notsuda, H. ^{[2
]}

Katsumata, S. ^{[1
]}

Hamada, A. ^{[4
]}

Nomura, K. ^{[5
]}

Fujino, K. ^{[6
]}

Yoshikawa, M. ^{[7
]}

Suzawa, K. ^{[7
]}

Shien, K. ^{[7
]}

Suda, K. ^{[4
]}

Ohara, S. ^{[4
]}

Fukuda, S. ^{[4
]}

Kinoshita, I. ^{[3
]}

Takamori, S. ^{[3
,8
]}

Muto, S. ^{[9
]}

Takanashi, Y. ^{[10
]}

Mizuno, K. ^{[10
]}

Kawase, A. ^{[10
]}

Hayakawa, T. ^{[10
]}

Sekihara, K.

Toda, M. ^{[11
]}

Matsuo, S. ^{[12
]}

Takegahara, K. ^{[13
]}

Hashimoto, M. ^{[13
]}

Nakahashi, K. ^{[14
]}

Endo, M. ^{[14
]}

Ozawa, H. ^{[15
]}

Fujikawa, R. ^{[15
]}

Tomioka, Y. ^{[16
]}

Namba, K. ^{[16
]}

Matsubara, T. ^{[17
]}

Suzuki, J. ^{[18
]}

Watanabe, H. ^{[18
]}

Takada, K. ^{[19
]}

Hoshino, H. ^{[20
]}

Toyoda, T. ^{[21
]}

Koki, Y. ^{[22
]}

Shiono, S. ^{[18
]}

Shimokawa, M. ^{[22
]}

Soh, J. ^{[23
]}

Ohde, Y. ^{[1
]}

Okada, Y. ^{[2
]}

机构：

[1] Shizuoka Canc Ctr, Shizuoka, Japan

[2] Tohoku Univ Hosp, Sendai, Miyagi, Japan

[3] Kyushu Univ, Fukuoka, Japan

[4] Kindai Univ, Fac Med, Osaka, Japan

[5] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[6] Kumamoto Univ, Kumamoto, Japan

[7] Okayama Univ Hosp, Okayama, Japan

[8] Oita Univ, Fac Med, Oita, Japan

[9] Fukushima Med Univ, Sch Med, Fukushima, Japan

[10] Hamamatsu Univ, Sch Med, Shizuoka, Japan

[11] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan

[12] Nihonkai Gen Hosp, Sakata, Yamagata, Japan

[13] Hyogo Coll Med, Nishinomiya, Hyogo, Japan

[14] Yamagata Prefectural Cent Hosp, Yamagata, Japan

[15] Shimada Gen Med Ctr, Shizuoka, Japan

[16] Shimane Univ, Matsue, Shimane, Japan

[17] Kitakyushu Municipal Med Ctr, Fukuoka, Japan

[18] Yamagata Univ, Yamagata, Japan

[19] Saiseikai Fukuoka Gen Hosp, Fukuoka, Japan

[20] NHO Okinawa Hosp, Okinawa, Japan

[21] Chiba Univ, Grad Sch Med, Chiba, Japan

[22] Yamaguchi Univ, Yamaguchi, Japan

[23] Osaka Metropolitan Univ, Grad Sch Med, Osaka, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期

关键词：

uncommon EGFR mutation; surgery; prognosis;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.07A.03

引用

页码：S232 / S233

页数：2

共 50 条

[31] Comprehensive Investigation of Uncommon EGFR Mutations in 14,429 Chinese Lung Cancer Patients
An, Y.
Wang, D.
Zhu, H.
Huang, J.
Wang, C.
Ma, T.
Zhang, X.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S602 - S603
[32] A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer
Tu, Hai-Yan
Ke, E-E
Yang, Jin-Ji
Sun, Yue-Li
Yan, Hong-Hong
Zheng, Ming-Ying
Bai, Xiao-Yan
Wang, Zhen
Su, Jian
Chen, Zhi-Hong
Zhang, Xu-Chao
Dong, Zhong-Yi
Wu, Si-Pei
Jiang, Ben-Yuan
Chen, Hua-Jun
Wang, Bin-Chao
Xu, Chong-Rui
Zhou, Qing
Mei, Ping
Luo, Dong-Lan
Zhong, Wen-zhao
Yang, Xue-Ning
Wu, Yi-Long
LUNG CANCER, 2017, 114 : 96 - 102
[33] Monitoring of cyclooxygenase-2 levels can predict EGFR mutations and the efficacy of EGFR-TKI in patients with lung adenocarcinoma
Li, Huanhuan
Wang, Yuli
Su, Fan
Li, Jing
Gong, Ping
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05): : 5577 - 5583
[34] Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations
Clay, T. D.
Russell, P. A.
Do, H.
Sundararajan, V.
Conron, M.
Wright, G. M.
Dobrovic, A.
Moore, M. M.
McLachlan, S. A.
PATHOLOGY, 2016, 48 (01) : 17 - 24
[35] Prognostic implications of immunohistochemistry markers for EGEGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations
Zhang, Ruiguang
Li, Yan
Nie, Xiu
Dong, Xiaorong
Wu, Gang
ONCOTARGETS AND THERAPY, 2016, 9 : 355 - 366
[36] EGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma
Chalela, Roberto
Bellosillo, Beatriz
Curull, Victor
Longaron, Raquel
Pascual-Guardia, Sergi
Badenes-Bonet, Diana
Arriola, Edurne
Sanchez-Font, Albert
Pijuan, Lara
Gea, Joaquim
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (04)
[37] Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
Liang, Sheng-Kai
Ko, Jen-Chung
Yang, James Chih-Hsin
Shih, Jin-Yuan
LUNG CANCER, 2019, 133 : 103 - 109
[38] Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations
Kim, Min Hwan
Kim, Hye Ryun
Cho, Byoung Chul
Bae, Mi Kyung
Kim, Eun Young
Lee, Chang Young
Lee, Jae Seok
Kang, Dae Ryong
Kim, Joo Hang
LUNG CANCER, 2014, 84 (02) : 196 - 202
[39] SURVIVAL ANALYSIS OF 106 FEMALE PATIENTS WITH COMPLETELY RESECTED LUNG ADENOCARCINOMA IN SHAANXI PROVINCE
Dai, Yun
Cao, Yanfei
Li, Wei
Tian, Wei
Dou, Yawei
Luo, Xianghui
Li, Shudong
Wang, Hongtao
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S629 - S630
[40] EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer
Fang, Shu
Wang, Zhehai
DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 1595 - 1611

← 1 2 3 4 5 →